Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?

被引：3
|
作者：
Sinha, Rajiv [1 ]
Dionne, Janis M. [1 ]
机构：
[1] British Columbia Childrens Hosp, Vancouver, BC, Canada
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2008年 / 93卷 / 05期
关键词：
D O I：
10.1136/adc.2007.131334
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：444 / 445
页数：4
相关论文
共 50 条
  • [1] Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosus
    Kado, Ruba
    McCune, W. Joseph
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2020, 64 : 97 - 106
  • [2] Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus
    Somers, EC
    Marder, W
    Christman, GM
    Ognenovski, V
    McCune, WJ
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2761 - 2767
  • [3] OVARIAN FUNCTION PRESERVATION WITH GONADOTROPIN-RELEASING HORMONE ANALOGUES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH CYCLOPHOSPHAMIDE
    Pacucci, V. A.
    Ceccarelli, F.
    Perrone, G.
    Zannini, I.
    Candelieri, M.
    Leccese, I.
    Perricone, C.
    Miranda, F.
    Truglia, S.
    Spinelli, F. R.
    Alessandri, C.
    Valesini, G.
    Conti, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 872 - 872
  • [4] Gonadotropin releasing hormone analogue in cyclophosphamide-induced premature gonadal failure prevention
    Gomez, J. Lopez
    Revert, P.
    Sivera, F.
    Moreno, O.
    De la Torre, J.
    Perdiguero, M.
    Vela, P.
    Batlle-Gualda, E.
    Martinez, A.
    Pascual, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 470 - 470
  • [5] Efficacy of Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in Women with Systemic Lupus Erythematosus (SLE) Receiving Cyclophosphamide (CYC)
    Chu, Jun
    Abid, Dania
    Manna, Zerai
    Paul, Subrata
    Ochoa, Isabel
    Wu, Yalan
    Goyal, Sonia
    Naqvi, Syed Ali Abbas
    Hooda, Lubna
    Hasni, Sarfaraz
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2979 - 2981
  • [6] Effects on bone mineral density (BMD) of gonadotropin-releasing hormone agonist (GNRH-A) for prevention of premature ovarian failure during cyclophosphamide therapy in women with severe systemic lupus
    Perez-Pampin, E.
    Maceiras-Pan, F.
    Figueiras, A.
    Mera-Varela, A.
    Carnota, J. Gomez-Reino
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 355 - 356
  • [7] Premature ovarian failure in systemic lupus erythematosus patients: is it related to cyclophosphamide treatment?
    Rasha M. Ghaleb
    Khaled A. Fahmy
    [J]. Egyptian Rheumatology and Rehabilitation, 2019, 46 (2) : 85 - 91
  • [8] ADMINISTRATION OF GONADOTROPIN-RELEASING HORMONE ANALOG AS ADJUNCTIVE THERAPY IN WOMEN WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    CATANIA, A
    MANGONE, I
    MOTTA, P
    ZANUSSI, C
    [J]. ARTHRITIS AND RHEUMATISM, 1989, 32 (09): : 1186 - 1188
  • [9] Use of Gonadotropin-releasing Hormone Agonists for Ovarian Preservation in Patients Receiving Cyclophosphamide for Systemic Lupus Erythematosus: A Meta-analysis
    Ejaz, Komal
    Abid, Dania
    Juneau, Paul
    Chu, Jun
    Hasni, Sarfaraz
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1912 - 1914
  • [10] Use of gonadotropin-releasing hormone agonists for ovarian preservation in patients receiving cyclophosphamide for systemic lupus erythematosus: A meta-analysis
    Ejaz, Komal
    Abid, Dania
    Juneau, Paul
    Chu, Jun
    Hasni, Sarfaraz
    [J]. LUPUS, 2022, 31 (14) : 1706 - 1713
12345